Dane Andreeff, Director at HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT), bought 245,330 shares at $2.70 ($637K) on 2017-11-09, disclosed to the SEC on 2017-11-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.70 | 7,293 | $20K | 3.1% |
| 2 | $2.70 | 19,610 | $53K | 8.3% |
| 3 | $2.70 | 33,097 | $89K | 14.0% |
| 4 | $2.70 | 33,097 | $89K | 14.0% |
| 5 | $2.59 | 9,967 | $26K | 4.1% |
| 6 | $2.59 | 26,800 |
| $69K |
| 10.9% |
| 7 | $2.59 | 45,233 | $117K | 18.4% |
| 8 | $2.59 | 45,233 | $117K | 18.4% |
| 9 | $2.23 | 3,039 | $7K | 1.1% |
| 10 | $2.23 | 8,171 | $18K | 2.9% |
| 11 | $2.23 | 13,790 | $31K | 4.8% |
| Total | $2.60 avg | 245,330 | $637K | 100% |
| Filing → |
| HSDT | BUY | 2023-08-30 | $71K | — | Filing → |
| HSDT | BUY | 2022-12-19 | $20K | — | Filing → |
| HSDT | BUY | 2022-11-25 | $29K | — | Filing → |